ID TPIS_RABIT Reviewed; 249 AA. AC P00939; G1TS29; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 07-OCT-2020, sequence version 3. DT 10-JUN-2026, entry version 157. DE RecName: Full=Triosephosphate isomerase {ECO:0000305|PubMed:2021650}; DE Short=TIM; DE EC=5.3.1.1 {ECO:0000269|PubMed:2021650}; DE AltName: Full=Methylglyoxal synthase {ECO:0000305|PubMed:2021650}; DE EC=4.2.3.3 {ECO:0000269|PubMed:2021650}; DE AltName: Full=Triose-phosphate isomerase; GN Name=TPI1; OS Oryctolagus cuniculus (Rabbit). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus. OX NCBI_TaxID=9986; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Thorbecke; RX PubMed=21993624; DOI=10.1038/nature10530; RA Lindblad-Toh K., Garber M., Zuk O., Lin M.F., Parker B.J., Washietl S., RA Kheradpour P., Ernst J., Jordan G., Mauceli E., Ward L.D., Lowe C.B., RA Holloway A.K., Clamp M., Gnerre S., Alfoldi J., Beal K., Chang J., RA Clawson H., Cuff J., Di Palma F., Fitzgerald S., Flicek P., Guttman M., RA Hubisz M.J., Jaffe D.B., Jungreis I., Kent W.J., Kostka D., Lara M., RA Martins A.L., Massingham T., Moltke I., Raney B.J., Rasmussen M.D., RA Robinson J., Stark A., Vilella A.J., Wen J., Xie X., Zody M.C., Baldwin J., RA Bloom T., Chin C.W., Heiman D., Nicol R., Nusbaum C., Young S., RA Wilkinson J., Worley K.C., Kovar C.L., Muzny D.M., Gibbs R.A., Cree A., RA Dihn H.H., Fowler G., Jhangiani S., Joshi V., Lee S., Lewis L.R., RA Nazareth L.V., Okwuonu G., Santibanez J., Warren W.C., Mardis E.R., RA Weinstock G.M., Wilson R.K., Delehaunty K., Dooling D., Fronik C., RA Fulton L., Fulton B., Graves T., Minx P., Sodergren E., Birney E., RA Margulies E.H., Herrero J., Green E.D., Haussler D., Siepel A., Goldman N., RA Pollard K.S., Pedersen J.S., Lander E.S., Kellis M.; RT "A high-resolution map of human evolutionary constraint using 29 mammals."; RL Nature 478:476-482(2011). RN [2] RP PROTEIN SEQUENCE OF 2-249. RX PubMed=1171682; DOI=10.1042/bj1450335; RA Corran P.H., Waley S.G.; RT "The amino acid sequence of rabbit muscle triose phosphate isomerase."; RL Biochem. J. 145:335-344(1975). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 57-84. RX PubMed=6687628; DOI=10.1038/302718a0; RA Putney S.D., Herlihy W.C., Schimmel P.R.; RT "A new troponin T and cDNA clones for 13 different muscle proteins, found RT by shotgun sequencing."; RL Nature 302:718-721(1983). RN [4] RP ACTIVE SITE. RX PubMed=4922541; DOI=10.1021/bi00777a021; RA Hartman F.C.; RT "Haloacetol phosphates. Characterization of the active site of rabbit RT muscle triose phosphate isomerase."; RL Biochemistry 10:146-154(1971). RN [5] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=2021650; DOI=10.1021/bi00232a031; RA Richard J.P.; RT "Kinetic parameters for the elimination reaction catalyzed by RT triosephosphate isomerase and an estimation of the reaction's physiological RT significance."; RL Biochemistry 30:4581-4585(1991). RN [6] RP PARTIAL PROTEIN SEQUENCE, AND DEAMIDATION AT ASN-16 AND ASN-72. RX PubMed=7574709; DOI=10.1006/abbi.1995.1476; RA Sun A.-Q., Yueksel U., Gracy R.W.; RT "Terminal marking of triosephosphate isomerase: consequences of RT deamidation."; RL Arch. Biochem. Biophys. 322:361-368(1995). RN [7] RP X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 2-249, AND HOMODIMERIZATION. RX PubMed=14643664; DOI=10.1016/j.jmb.2003.10.022; RA Aparicio R., Ferreira S.T., Polikarpov I.; RT "Closed conformation of the active site loop of rabbit muscle RT triosephosphate isomerase in the absence of substrate: evidence of RT conformational heterogeneity."; RL J. Mol. Biol. 334:1023-1041(2003). CC -!- FUNCTION: Triosephosphate isomerase is an extremely efficient metabolic CC enzyme that catalyzes the interconversion between dihydroxyacetone CC phosphate (DHAP) and D-glyceraldehyde-3-phosphate (G3P) in glycolysis CC and gluconeogenesis. {ECO:0000305|PubMed:2021650}. CC -!- FUNCTION: It is also responsible for the non-negligible production of CC methylglyoxal a reactive cytotoxic side-product that modifies and can CC alter proteins, DNA and lipids. {ECO:0000269|PubMed:2021650}. CC -!- CATALYTIC ACTIVITY: CC Reaction=D-glyceraldehyde 3-phosphate = dihydroxyacetone phosphate; CC Xref=Rhea:RHEA:18585, ChEBI:CHEBI:57642, ChEBI:CHEBI:59776; CC EC=5.3.1.1; Evidence={ECO:0000269|PubMed:2021650}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18586; CC Evidence={ECO:0000305|PubMed:2021650}; CC PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18587; CC Evidence={ECO:0000305|PubMed:2021650}; CC -!- CATALYTIC ACTIVITY: CC Reaction=dihydroxyacetone phosphate = methylglyoxal + phosphate; CC Xref=Rhea:RHEA:17937, ChEBI:CHEBI:17158, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:57642; EC=4.2.3.3; Evidence={ECO:0000269|PubMed:2021650}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=0.62 mM for dihydroxyacetone phosphate (at pH 7.9) CC {ECO:0000269|PubMed:2021650}; CC Note=The kcat is 900 sec(-1) for the isomerization of CC dihydroxyacetone phosphate (PubMed:2021650). The kcat is 0.011 CC sec(-1) for the production of methylglyoxal via the elimination CC reaction (PubMed:2021650). Produces methylglyoxal with a calculated CC cellular velocity of 0.4 mM per day (PubMed:2021650). CC {ECO:0000269|PubMed:2021650}; CC -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3- CC phosphate from glycerone phosphate: step 1/1. {ECO:0000255|PROSITE- CC ProRule:PRU10127}. CC -!- PATHWAY: Carbohydrate biosynthesis; gluconeogenesis. CC {ECO:0000255|PROSITE-ProRule:PRU10127}. CC -!- SUBUNIT: Homodimer. {ECO:0000255|PROSITE-ProRule:PRU10127, CC ECO:0000269|PubMed:14643664}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|PROSITE-ProRule:PRU10127}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative initiation; Named isoforms=2; CC Name=1; CC IsoId=P00939-1; Sequence=Displayed; CC Name=2; CC IsoId=P00939-2; Sequence=VSP_060725; CC -!- PTM: Asn-16 and Asn-72 undergo deamidation which gives rise to four CC extra negative charges. These are expected to decrease subunit-subunit CC interactions and so expose the hydrophobic interface to the aqueous CC environment. {ECO:0000269|PubMed:7574709}. CC -!- SIMILARITY: Belongs to the triosephosphate isomerase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AAGW02051581; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; V00902; CAA24267.1; -; mRNA. DR PIR; A01165; ISRBT. DR RefSeq; XP_002712957.1; XM_002712911.4. [P00939-2] DR PDB; 1R2R; X-ray; 1.50 A; A/B/C/D=2-249. DR PDB; 1R2S; X-ray; 2.85 A; A/B/C/D=2-249. DR PDB; 1R2T; X-ray; 2.25 A; A/B=2-249. DR PDB; 4OWG; X-ray; 1.55 A; A/B=2-249. DR AlphaFoldDB; P00939; -. DR SMR; P00939; -. DR FunCoup; P00939; 1205. DR STRING; 9986.ENSOCUP00000019840; -. DR BindingDB; P00939; -. DR ChEMBL; CHEMBL3930; -. DR PaxDb; 9986-ENSOCUP00000019840; -. DR Ensembl; ENSOCUT00000025399.1; ENSOCUP00000019840.1; ENSOCUG00000025649.1. [P00939-2] DR GeneID; 100348316; -. DR KEGG; ocu:100348316; -. DR CTD; 7167; -. DR eggNOG; KOG1643; Eukaryota. DR GeneTree; ENSGT00390000013354; -. DR HOGENOM; CLU_024251_2_0_1; -. DR InParanoid; P00939; -. DR OMA; NWKMHMT; -. DR OrthoDB; 6715177at2759; -. DR BRENDA; 5.3.1.1; 1749. DR SABIO-RK; P00939; -. DR UniPathway; UPA00109; UER00189. DR UniPathway; UPA00138; -. DR EvolutionaryTrace; P00939; -. DR Proteomes; UP000001811; Chromosome 8. DR Bgee; ENSOCUG00000025649; Expressed in skeletal muscle tissue and 18 other cell types or tissues. DR GO; GO:0005829; C:cytosol; IEA:Ensembl. DR GO; GO:0008929; F:methylglyoxal synthase activity; IDA:UniProtKB. DR GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB. DR GO; GO:0004807; F:triose-phosphate isomerase activity; IDA:UniProtKB. DR GO; GO:0031625; F:ubiquitin protein ligase binding; IEA:Ensembl. DR GO; GO:0061621; P:canonical glycolysis; IEA:Ensembl. DR GO; GO:0006094; P:gluconeogenesis; IEA:UniProtKB-UniPathway. DR GO; GO:0046166; P:glyceraldehyde-3-phosphate biosynthetic process; IDA:UniProtKB. DR GO; GO:0019563; P:glycerol catabolic process; IEA:TreeGrafter. DR GO; GO:0019242; P:methylglyoxal biosynthetic process; IDA:UniProtKB. DR CDD; cd00311; TIM; 1. DR FunFam; 3.20.20.70:FF:000025; Triosephosphate isomerase; 1. DR Gene3D; 3.20.20.70; Aldolase class I; 1. DR HAMAP; MF_00147_B; TIM_B; 1. DR InterPro; IPR013785; Aldolase_TIM. DR InterPro; IPR035990; TIM_sf. DR InterPro; IPR022896; TrioseP_Isoase_bac/euk. DR InterPro; IPR000652; Triosephosphate_isomerase. DR InterPro; IPR020861; Triosephosphate_isomerase_AS. DR NCBIfam; TIGR00419; tim; 1. DR PANTHER; PTHR21139; TRIOSEPHOSPHATE ISOMERASE; 1. DR PANTHER; PTHR21139:SF2; TRIOSEPHOSPHATE ISOMERASE; 1. DR Pfam; PF00121; TIM; 1. DR SUPFAM; SSF51351; Triosephosphate isomerase (TIM); 1. DR PROSITE; PS00171; TIM_1; 1. DR PROSITE; PS51440; TIM_2; 1. DR PDBsum; 1R2R; -. DR PDBsum; 1R2S; -. DR PDBsum; 1R2T; -. DR PDBsum; 4OWG; -. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Alternative initiation; Cytoplasm; KW Direct protein sequencing; Gluconeogenesis; Glycolysis; Isomerase; KW Isopeptide bond; Lyase; Methylation; Nitration; Phosphoprotein; KW Reference proteome; Ubl conjugation. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:P60174" FT CHAIN 2..249 FT /note="Triosephosphate isomerase" FT /id="PRO_0000090119" FT ACT_SITE 96 FT /note="Electrophile" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10127" FT ACT_SITE 166 FT /note="Proton acceptor" FT /evidence="ECO:0000269|PubMed:4922541" FT BINDING 12 FT /ligand="substrate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10127" FT BINDING 14 FT /ligand="substrate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10127" FT MOD_RES 14 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P60174" FT MOD_RES 16 FT /note="Deamidated asparagine" FT /evidence="ECO:0000269|PubMed:7574709" FT MOD_RES 68 FT /note="3'-nitrotyrosine" FT /evidence="ECO:0000250|UniProtKB:P17751" FT MOD_RES 72 FT /note="Deamidated asparagine" FT /evidence="ECO:0000269|PubMed:7574709" FT MOD_RES 80 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P60174" FT MOD_RES 106 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P48500" FT MOD_RES 149 FT /note="N6-succinyllysine" FT /evidence="ECO:0000250|UniProtKB:P17751" FT MOD_RES 156 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P17751" FT MOD_RES 156 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P17751" FT MOD_RES 159 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P17751" FT MOD_RES 173 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P17751" FT MOD_RES 194 FT /note="N6-acetyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P60174" FT MOD_RES 194 FT /note="N6-methyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P60174" FT MOD_RES 194 FT /note="N6-succinyllysine; alternate" FT /evidence="ECO:0000250|UniProtKB:P17751" FT MOD_RES 198 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P48500" FT MOD_RES 209 FT /note="3'-nitrotyrosine" FT /evidence="ECO:0000250|UniProtKB:P17751" FT MOD_RES 212 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P60174" FT MOD_RES 214 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P60174" FT MOD_RES 223 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P60174" FT MOD_RES 238 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P60174" FT CROSSLNK 142 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO1)" FT /evidence="ECO:0000250|UniProtKB:P60174" FT VAR_SEQ 1 FT /note="M -> MAGTGQEAEFRFSAFYISRQRPQPRPHGGTDLQCAGPSAM (in FT isoform 2)" FT /evidence="ECO:0000305" FT /id="VSP_060725" FT HELIX 4..6 FT /evidence="ECO:0007829|PDB:1R2S" FT STRAND 7..12 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 19..31 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 33..35 FT /evidence="ECO:0007829|PDB:1R2S" FT STRAND 38..43 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 46..48 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 49..55 FT /evidence="ECO:0007829|PDB:1R2R" FT STRAND 60..65 FT /evidence="ECO:0007829|PDB:1R2R" FT STRAND 69..74 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 81..86 FT /evidence="ECO:0007829|PDB:1R2R" FT STRAND 91..95 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 97..101 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 107..119 FT /evidence="ECO:0007829|PDB:1R2R" FT STRAND 123..128 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 132..136 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 140..153 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 158..160 FT /evidence="ECO:0007829|PDB:1R2R" FT STRAND 161..165 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 168..170 FT /evidence="ECO:0007829|PDB:1R2R" FT STRAND 171..174 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 176..178 FT /evidence="ECO:0007829|PDB:4OWG" FT HELIX 179..196 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 199..204 FT /evidence="ECO:0007829|PDB:1R2R" FT STRAND 207..209 FT /evidence="ECO:0007829|PDB:1R2R" FT TURN 215..217 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 218..222 FT /evidence="ECO:0007829|PDB:1R2R" FT STRAND 229..233 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 234..237 FT /evidence="ECO:0007829|PDB:1R2R" FT HELIX 240..245 FT /evidence="ECO:0007829|PDB:1R2R" FT TURN 246..248 FT /evidence="ECO:0007829|PDB:4OWG" SQ SEQUENCE 249 AA; 26757 MW; F794DE966AC70D81 CRC64; MAPSRKFFVG GNWKMNGRKK NLGELITTLN AAKVPADTEV VCAPPTAYID FARQKLDPKI AVAAQNCYKV TNGAFTGEIS PGMIKDCGAT WVVLGHSERR HVFGESDELI GQKVAHALSE GLGVIACIGE KLDEREAGIT EKVVFEQTKV IADNVKDWSK VVLAYEPVWA IGTGKTATPQ QAQEVHEKLR GWLKSNVSDA VAQSTRIIYG GSVTGATCKE LASQPDVDGF LVGGASLKPE FVDIINAKQ //